D&I Projects
Stagewise Implementation to Target – Medications for Addiction Treatment (SITT-MAT)
SITT-MAT is a five-year, NIDA-funded R01 (1R01DA052975-01A1) designed to improve patient access to medications for opioid use disorder within specialty addiction programs and primary care clinics in Washington State. Led by Stanford University (PI: Mark McGovern) and the University of Wisconsin (PI: Jay Ford), SITT-MAT partners with the Washington State Health Care Authority to offer implementation support to 64 primary care clinics and specialty addiction treatment programs based on target implementation outcomes. This innovative project uses a stepped implementation model where implementation supports of increasing intensity and cost are delivered only if less intensive implementation support do not achieve target outcomes. Implementation support strategies are:
- Enhanced monitoring and feedback;
- Two-day workshop;
- Internal facilitation; and
- External facilitation.
Findings from SITT-MAT have the potential to inform implementation research and provide key decision-makers with practical information on how to address the opioid epidemic at a systems level. For more information about SITT-MAT, visit this page.
Mark McGovern
Stanford University School of Medicine
Director
Dr. Mark McGovern directs the Center for Dissemination and Implementation. His work focuses on implementation science, with emphasis on integrated behavioral health services for persons with co-occurring substance use and psychiatric disorders in both primary care and specialty settings. He actively collaborates with health systems, including Stanford Health Care and Intermountain Healthcare, on developing implementable and sustainable models of integrated behavioral health in primary care practice. His research interests also include scaling up access to FDA-approved medications in specialty care and in general medical practice settings.
Hannah Cheng
Stanford University School of Medicine
Research Analyst
Hannah Cheng, MS, joined CDI in 2019 and transitioned into a research analyst role in 2022. Her work at CDI primarily focuses on implementing addiction treatments in primary care and specialty care settings. She is dedicated to understanding how to optimize implementation efforts and applying implementation science to improve equity and access to mental health services. Hannah received her BS in Psychology and Neuroscience from the University of Pittsburgh and her MS in Epidemiology and Clinical Research from Stanford University.
Jay Ford
University of Wisconsin-Madison
Principal Investigator
Kim Mount
Washington State Health Care Authority
Project Director
Tony Walton
Washington State Health Care Authority
Co-Investigator
Ryan Keith
Washington State Health Care Authority
Project Partner
Collaborators
C. Hendricks Brown, Co-Investigator, Northwestern University
Lisa Saldana, Co-Investigator, Oregon Social Learning Center
Todd Wagner, Co-Investigator, Stanford University School of Medicine
More Projects
Addiction Treatment Starts Here (ATSH)
Addiction Treatment Starts Here (ATSH) is a collaboration between CDI and the Center for Care Innovations to increase access to medications for addiction treatment (MAT) in safety-net primary care clinics across the State of California. Since its launch in 2019, ATSH has supported over 100 safety-net clinics in designing new or expanding existing MAT programs. The ATSH initiative is funded by the California Department of Health Care Services through the State of California’s State Opioid Response grant. For more information about ATSH, visit this page.
Integrated Behavioral Health in Primary Care (IBHPC)
In collaboration with primary care leaders in the Stanford Health Care system, IBHPC is being implemented in Stanford Primary Care, Employer Based Clinics and affiliated primary care clinics. This integrated model is designed to increase the identification and treatment of behavioral health issues, including mental health and substance use issues. The goal is to support patients with behavioral health problems within their primary care experience and, when needed, coordinate care with specialty psychiatric services. Ongoing projects are evaluating staff perceptions and current state of behavioral health practices; installation of depression screening using technology platforms; developing electronic health record supports: and integrating consulting psychiatry and integrated social work personnel.
Addressing Methamphetamine Use Disorders in Primary Care
CDI, in collaboration with the University of California Los Angeles Integrated Substance Abuse Programs (ISAP), is evaluating the current practice and needs of primary care providers in addressing methamphetamine use problems among their patients. The project is funded by the State of California Department of Health Care Services, as a component of the federal State Opioid Response Grant. Both qualitative and quantitative approaches are being used to understand current practice patterns, barriers and facilitators to providing quality care, and perceived needs for enhancing existing services. Additionally, a pilot study of a multicomponent intervention, the Treatment and Recovery for Users of Stimulants (TRUST), is being implemented among patients receiving substance use disorder treatment in publicly-funded specialty addiction treatment settings. TRUST implementation was evaluated using mixed methods to understand the barriers and facilitators to protocol adherence and potential sustainability of the intervention. Both projects seek to improve care quality across healthcare settings to prevent overdose deaths and long-term complications associated with methamphetamine use.
D&I Tools and Resources
Below are organizational measures we've developed and refined to aid in the implementation of mental health and substance use treatment services.
